Weekly Market HighlightsMarket breadth was slightly positive on the week, with 4,831 advancers versus 4,694 decliners.Returns were highly skewed, with 491 stoc
Companies looking to sell weight-loss drugs directly to consumers, including Novo Nordisk's Wegovy, will shell out millions of dollars for celebrity-filled ads during Sunday's Super Bowl with its prom
In its latest earnings report, Eli Lilly and Company NYSE: LLY once again showed why it has become by far one of the world's most valuable healthcare stocks. Year-to-date, Eli Lilly's market capitali
Eli Lilly and Novo Nordisk dominate the weight loss drug market. Both companies have generated significant growth thanks to these drugs over the past few years.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Shares of Hims and Hers Health (HIMS) came under renewed pressure Friday, falling roughly 8% in premarket trading after FDA Commissioner Marty Makary said the age
Major stock indexes opened higher Friday, a day after equities sank amid risk-off sentiment. Still, the Nasdaq and S&P 500 were poised to register sharp weekly losses.

First Look: Amazon's $200B AI Bet, Tech Rout

07:37am, Friday, 06'th Feb 2026
Stock News Amazon hikes AI capex: Amazon (AMZN) warned 2026 capital expenditures will surge to about $200 billion, focused largely on AWS and AI infrastructure,
Stock News Amazon lifts 2026 capex to ~$200B: Amazon (AMZN) posted a Q4 EPS miss but revenue beat and guided 2026 capital expenditures to about $200 billion, pr

Eli Lilly: Positives Outweigh The Concerns

05:28pm, Thursday, 05'th Feb 2026
Eli Lilly and Company's price jump following its latest earnings release is completely justified going by both the performance and guidance. Both LLY revenue and EPS growth exceeded guidance, despite
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of V
NEW YORK--(BUSINESS WIRE)---- $LLY #NYSE--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the leadership
Eli Lilly has seen earnings soar thanks to its leadership in the weight loss drug market. The company's weight loss portfolio brought in more than $11 billion in revenue in the recent quarter.
Eli Lilly and Co. (NYSE: LLY) stock is trading lower on Thursday, possibly on profit-taking after the stock rallied roughly 10% on Wednesday.
Online telehealth company Hims & Hers will launch a copy of the newly launched Wegovy pill for $49, far less than the $149 Novo sells the branded pill for. Novo Nordisk and chief rival Eli Lilly stock
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE